These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT Sekssaoui M; Bockaert J; Marin P; Bécamel C Neuropsychopharmacology; 2024 Mar; 49(4):747-756. PubMed ID: 38212441 [TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of nonhallucinogenic psychedelic analogs. Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960 [TBL] [Abstract][Full Text] [Related]
4. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties. Puigseslloses P; Nadal-Gratacós N; Ketsela G; Weiss N; Berzosa X; Estrada-Tejedor R; Islam MN; Holy M; Niello M; Pubill D; Camarasa J; Escubedo E; Sitte HH; López-Arnau R Mol Psychiatry; 2024 Aug; 29(8):2346-2358. PubMed ID: 38486047 [TBL] [Abstract][Full Text] [Related]
6. Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice. Qu Y; Chang L; Ma L; Wan X; Hashimoto K Pharmacol Biochem Behav; 2023 Jan; 222():173500. PubMed ID: 36476377 [TBL] [Abstract][Full Text] [Related]
7. [Contribution of serotonin 5-HT Ibi D Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794 [TBL] [Abstract][Full Text] [Related]
8. "Selective" serotonin 5-HT Casey AB; Cui M; Booth RG; Canal CE Biochem Pharmacol; 2022 Jun; 200():115028. PubMed ID: 35381208 [TBL] [Abstract][Full Text] [Related]
9. Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT Pottie E; Dedecker P; Stove CP Biochem Pharmacol; 2020 Dec; 182():114251. PubMed ID: 32998000 [TBL] [Abstract][Full Text] [Related]
10. Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances. Pottie E; Cannaert A; Van Uytfanghe K; Stove CP Anal Chem; 2019 Dec; 91(24):15444-15452. PubMed ID: 31725281 [TBL] [Abstract][Full Text] [Related]
12. Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice. de la Fuente Revenga M; Shah UH; Nassehi N; Jaster AM; Hemanth P; Sierra S; Dukat M; González-Maeso J ACS Chem Neurosci; 2021 Mar; 12(5):831-844. PubMed ID: 33400504 [TBL] [Abstract][Full Text] [Related]
13. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012 [TBL] [Abstract][Full Text] [Related]
14. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Vargas MV; Dunlap LE; Dong C; Carter SJ; Tombari RJ; Jami SA; Cameron LP; Patel SD; Hennessey JJ; Saeger HN; McCorvy JD; Gray JA; Tian L; Olson DE Science; 2023 Feb; 379(6633):700-706. PubMed ID: 36795823 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress. Liu G; Ma L; Qu Y; Wan X; Xu D; Zhao M; Murayama R; Hashimoto K Pharmacol Biochem Behav; 2023 Dec; 233():173659. PubMed ID: 37844631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]